5 completed. 4 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Completed 4 |
Follow Keystone Heart: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The REFLECT Trial: Cerebral Protection to Reduce Cerebral Embolic Lesions After Transcatheter Aortic Valve Implantation Embolic Protection Device, Transcatheter aortic valve implantation (TAVI) - Symptomatic Aortic Stenosis | Not applicable | Completed | Keystone Heart | 478 | 2016-06-01 | 2021-02-18 |
| DEFLECT III: A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During TAVI TriGuard HDH - Aortic Valve Stenosis | Not applicable | Completed | Keystone Heart | 86 | 2014-02-01 | 2015-08-27 |
| DEFLECT II: A Study to Evaluate the Safety and Performance of the TriGuard™HDH in Patients Undergoing TAVR TriGuard™HDH - Aortic Valve Stenosis | Not applicable | Completed | Keystone Heart | 12 | 2014-01-01 | 2015-08-27 |
| A Study to Evaluate the Neuro-embolic Consequences of TAVR Aortic Valve Stenosis | Completed | Keystone Heart | 46 | 2013-11-01 | 2015-08-27 | |
| DEFLECT I: Keystone Heart Embolic Deflection Trial Keystone Heart Embolic Deflection Device - Aortic Stenosis | Not applicable | Completed | Keystone Heart | 37 | 2012-03-01 | 2020-09-14 |
Aortic Valve Stenosis (5) · Constriction, Pathologic (1)
Embolic Protection Devices (1) · Transcatheter Aortic Valve Replacement (1)
Netherlands (3) · Germany (2) · Italy (2) · United States (2) · France (1) · Israel (1) · United Kingdom (1)
Alexandra J Lansky, MD (1) · Alexandra Lansky, Md. (1) · Andreas Baumbach, Md. (1) · Michael Mullen, Md. (1) · Pieter Stella, Md. (1)